Theravance Inc. (THRX) Stock News, Earnings & History

(NASDAQ:THRX) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 42.41
52wk low: 17.06
EPS: -1.51
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 3.73B
Avg Vol (3m): 1.54M

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mammen Mathai SVP, Research & Early Clin Dev Feb 20 Sale 22.14 7,000 154,980 212,976 Feb 22 07:03 PM
Mammen Mathai SVP, Research & Early Clin Dev Jan 11 Option Exercise 3.10 14,510 44,981 220,438 Jan 14 07:04 PM
Mammen Mathai SVP, Research & Early Clin Dev Nov 14 Option Exercise 3.10 5,161 15,999 210,802 Nov 16 07:01 PM
Mammen Mathai SVP, Research & Early Clin Dev Nov 02 Sale 21.45 7,000 150,162 205,641 Nov 06 07:01 PM
Aguiar Michael W Sr VP, Chief Financial Officer Aug 27 Sale 27.33 20,561 561,855 132,486 Aug 28 07:01 PM
Aguiar Michael W Sr VP, Chief Financial Officer Aug 24 Option Exercise 17.91 4,121 73,807 157,168 Aug 28 07:01 PM
Brinkley David L Head of Business Dev. Aug 24 Sale 27.50 3,483 95,783 60,241 Aug 28 07:02 PM
Aguiar Michael W Sr VP, Chief Financial Officer Aug 24 Sale 28.01 4,121 115,429 153,047 Aug 28 07:01 PM
Mammen Mathai SVP, Research & Early Clin Dev Aug 13 Sale 25.74 25,000 643,461 212,285 Aug 15 07:05 PM
Aguiar Michael W Sr VP, Chief Financial Officer Aug 07 Option Exercise 16.25 60,000 975,000 217,924 Aug 09 07:00 PM
Yahoo, HV, Market Watch, The Wall St. Journal